RxDoctor Payments Data

Dana Granberg-Nill

Family Medicine · Kansas City, MONPI 1336103522

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.4% of the total. Reporting peaked in 2019 at $715 and has fallen 96.2% since, to $27 in 2022.

$2,082in general payments, 2019–2025

Across 136 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$528
  • AstraZeneca$265
  • Boehringer Ingelheim$202
  • Lilly USA, LLC$189
  • Novo Nordisk$132
  • Johnson & Johnson$105
  • plus $661 from 16 others

What the payments were for

  • Food & beverage$2,080100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,082 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Other family medicine in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →